期刊
HUMAN MUTATION
卷 40, 期 4, 页码 392-403出版社
WILEY
DOI: 10.1002/humu.23703
关键词
primary familial brain calcification; PFBC; mutation spectrum; XPR1; functional assay
资金
- National Natural Science Foundation of China (NSFC) [81322017, 81771230, U1505222, 81801129]
- National Key Clinical Specialty Discipline Construction Program
- Key Clinical Specialty Discipline Construction Program of Fujian
- Joint Funds for the Innovation of Science and Technology of Fujian Province [2017Y9094]
- Startup Fund for Scientific Research, Fujian Medical University [2017XQ1071]
Primary familial brain calcification (PFBC) is a rare neurodegenerative disorder with four causative genes (SLC20A2, PDGFRB, PDGFB, and XPR1) that have been identified. Here, we aim to describe the mutational spectrum of four causative genes in a series of 226 unrelated Chinese PFBC patients. Mutations in four causative genes were detected in 16.8% (38/226) of PFBC patients. SLC20A2 mutations accounted for 14.2% (32/226) of all patients. Mutations in the other three genes were relatively rare, accounting for 0.9% (2/226) of all patients, respectively. Clinically, 44.8% of genetically confirmed patients (probands and relatives) were considered symptomatic. The most frequent symptoms were chronic headache, followed by movement disorders and vertigo. Moreover, the total calcification score was significantly higher in the symptomatic group compared to the asymptomatic group. Functionally, we observed impaired phosphate transport induced by seven novel missense mutations in SLC20A2 and two novel mutations in XPR1. The mutation p.D164Y in XPR1 might result in low protein expression through an enhanced proteasome pathway. In conclusion, our study further confirms that mutations in SLC20A2 are the major cause of PFBC and provides additional evidence for the crucial roles of phosphate transport impairment in the pathogenies of PFBC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据